ProCE Banner Activity

Novel Therapeutic Strategies for MDS Focused on the Stroma and Immuno-oncology

Slideset Download
Download these slides from a live webinar for updates on immuno-oncology therapeutic strategies in MDS

Released: December 10, 2021

Expiration: December 09, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gamida Cell Ltd

Geron

Gilead Sciences, Inc.

Karyopharm Therapeutics Inc.

Takeda Pharma USA Inc Takeda Onc Co

Faculty Disclosure

Primary Author

Amer Zeidan, MBBS, MHS

Professor of Internal Medicine
Chief, Division of Hematologic Malignancies
Assistant Medical Director, Hematology Clinical Trials Office (CTO)
Director, Hematology Early Therapeutics Research
Director, Leukemia and Myeloid Malignancies Program
Co-Leader, Leukemia and Myeloid Malignancies Clinical Research Team (CRT)
Section of Medical Oncology and Hematology, Department of Internal Medicine
Yale School of Medicine and Yale Comprehensive Cancer Center
New Haven, Connecticut